Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union Read more about Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer Read more about Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe Read more about Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
Amgen Positioned to Deliver Attractive Growth Over Next Five Years Read more about Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York Read more about Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
Call for Applications: The Amgen Award for Science Teaching Excellence Read more about Call for Applications: The Amgen Award for Science Teaching Excellence
Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis Read more about Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 Read more about Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
Amgen Announces Webcast of 2008 Third Quarter Financial Results Read more about Amgen Announces Webcast of 2008 Third Quarter Financial Results
Amgen Issues Statement on Court of Appeals Ruling That Affirms Preliminary Injunction Against Roche Read more about Amgen Issues Statement on Court of Appeals Ruling That Affirms Preliminary Injunction Against Roche
